These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30046247)

  • 1. Pathogenesis and management of adenoviral keratoconjunctivitis.
    Chigbu DI; Labib BA
    Infect Drug Resist; 2018; 11():981-993. PubMed ID: 30046247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparate Entry of Adenoviruses Dictates Differential Innate Immune Responses on the Ocular Surface.
    Pennington MR; Saha A; Painter DF; Gavazzi C; Ismail AM; Zhou X; Chodosh J; Rajaiya J
    Microorganisms; 2019 Sep; 7(9):. PubMed ID: 31540200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad sialic acid usage amongst species D human adenovirus.
    Mundy RM; Baker AT; Bates EA; Cunliffe TG; Teijeira-Crespo A; Moses E; Rizkallah PJ; Parker AL
    Npj Viruses; 2023; 1(1):1. PubMed ID: 38665237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Adenoviral Keratoconjunctivitis: Challenges and Solutions.
    Labib BA; Minhas BK; Chigbu DI
    Clin Ophthalmol; 2020; 14():837-852. PubMed ID: 32256043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seasonal Variation in Human Adenovirus Conjunctivitis: A 30-Year Observational Study.
    Lee J; Bilonick RA; Romanowski EG; Kowalski RP
    Ophthalmic Epidemiol; 2018; 25(5-6):451-456. PubMed ID: 30118359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mystery eye: Human adenovirus and the enigma of epidemic keratoconjunctivitis.
    Jonas RA; Ung L; Rajaiya J; Chodosh J
    Prog Retin Eye Res; 2020 May; 76():100826. PubMed ID: 31891773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in management of epidemic keratoconjunctivitis with emerging recombinant human adenoviruses.
    Gonzalez G; Yawata N; Aoki K; Kitaichi N
    J Clin Virol; 2019 Mar; 112():1-9. PubMed ID: 30654207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjunctivitis: A Systematic Review.
    Azari AA; Arabi A
    J Ophthalmic Vis Res; 2020; 15(3):372-395. PubMed ID: 32864068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodine povidone. A new paradigm in the treatment of adenoviral conjunctivitis?
    González-Martín-Moro J; Zarallo-Gallardo J
    Arch Soc Esp Oftalmol (Engl Ed); 2019 Nov; 94(11):521-522. PubMed ID: 31500885
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety and tolerability of a one-time, in-office administration of 5% povidone-iodine in the treatment of adenoviral conjunctivitis: The Reducing Adenoviral Patient Infected Days (RAPID) study.
    Shorter E; Whiteside M; Harthan J; Margolis MS; Hartwick AT; Johnson S; Migneco M; Morettin C; Olson CK; Huecker J; Than T; Gordon MO
    Ocul Surf; 2019 Oct; 17(4):828-832. PubMed ID: 31401340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Topical Steroids in Conjunctivitis: A Review of the Evidence.
    Holland EJ; Fingeret M; Mah FS
    Cornea; 2019 Aug; 38(8):1062-1067. PubMed ID: 31276464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A treatment protocol for minimizing duration and complications of adenoviral epidemic keratoconjunctivitis.
    Kulkarni C; Ballal K
    Taiwan J Ophthalmol; 2020; 10(4):269-277. PubMed ID: 33437600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19).
    Cheema M; Aghazadeh H; Nazarali S; Ting A; Hodges J; McFarlane A; Kanji JN; Zelyas N; Damji KF; Solarte C
    Can J Ophthalmol; 2020 Aug; 55(4):e125-e129. PubMed ID: 32284146
    [No Abstract]   [Full Text] [Related]  

  • 14. Global Prevalence of Preexisting Antibodies against Human Adenoviruses, Surveyed from 1962 to 2021.
    Luo H; Zhou Q; Feng J; Wu Y; Chen H; Mao M; Qi R
    Intervirology; 2024; 67(1):19-39. PubMed ID: 38452738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common and Potential Emerging Foodborne Viruses: A Comprehensive Review.
    Olaimat AN; Taybeh AO; Al-Nabulsi A; Al-Holy M; Hatmal MM; Alzyoud J; Aolymat I; Abughoush MH; Shahbaz H; Alzyoud A; Osaili T; Ayyash M; Coombs KM; Holley R
    Life (Basel); 2024 Jan; 14(2):. PubMed ID: 38398699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution and diversity of human adenoviruses isolated from patients with keratoconjunctivitis.
    Karami C; Mazloum Jalali K; Jalilian S; Khataminia G; Biparva Haghighi S; Karimi Babaahmadi M; Taherkhani R; Makvandi M
    Iran J Microbiol; 2022 Jun; 14(3):402-409. PubMed ID: 37124862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case for conservative management of adenoviral pseudomembranous conjunctivitis.
    Gilmour KM; Ramaesh K
    BMJ Case Rep; 2023 Feb; 16(2):. PubMed ID: 36810328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro efficacy of cyclosporine a and various antiseptics and antiviral drugs on adenovirus genotype 8, a common cause of epidemic keratoconjunctivitis.
    Aydamirov AS; Harbiyeli II; Ozturk G; Yarkin F; Erdem E; Yagmur M
    Int Ophthalmol; 2023 May; 43(5):1701-1710. PubMed ID: 36346478
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.